US 12,071,651 B2
Dilution tagging for quantification of biological targets
David Tsao, Menlo Park, CA (US); Patrick Ye, Menlo Park, CA (US); Sukrit Silas, Menlo Park, CA (US); and Oguzhan Atay, Menlo Park, CA (US)
Assigned to BillionToOne, Inc., Menlo Park, CA (US)
Filed by BillionToOne, Inc., Menlo Park, CA (US)
Filed on Aug. 6, 2019, as Appl. No. 16/533,444.
Claims priority of provisional application 62/715,175, filed on Aug. 6, 2018.
Prior Publication US 2020/0040380 A1, Feb. 6, 2020
Int. Cl. C12Q 1/6816 (2018.01); C12Q 1/6806 (2018.01); C12Q 1/6851 (2018.01); C12Q 1/6853 (2018.01); C12Q 1/6876 (2018.01); G16B 40/10 (2019.01)
CPC C12Q 1/6816 (2013.01) [C12Q 1/6806 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/6853 (2013.01); C12Q 1/6876 (2013.01); G16B 40/10 (2019.02); C12Q 2525/161 (2013.01); C12Q 2525/179 (2013.01); C12Q 2537/143 (2013.01); C12Q 2545/114 (2013.01); C12Q 2600/166 (2013.01)] 20 Claims
 
1. A method for determination of abundance of a nucleic acid target from a sample including cell-free DNA (cfDNA), the method comprising:
generating a first set of oligonucleotides comprising different subsets of oligonucleotides, wherein each subset of the different subsets of oligonucleotides comprises oligonucleotides comprising:
a dilution tag sequence associated with the subset of the different subsets of oligonucleotides, wherein the dilution tag sequence is associated with a relative concentration profile indicating different relative concentrations of different dilution tag sequence combinations, and
a target-specific region complementary to a target sequence of the nucleic acid target;
generating a second set of oligonucleotides comprising dilution tag sequence-associated regions complementary to nucleotide sequences of the dilution tag sequences of the first set of oligonucleotides;
performing a labeling process with the first set of oligonucleotides and the cfDNA from the sample, thereby generating a dilution-tagged mixture comprising different subsets of the dilution-tagged nucleic acid target identified by the different dilution tag sequence combinations at different relative concentrations indicated by the relative concentration profile;
performing an amplification process with the second set of oligonucleotides and the dilution-tagged mixture;
modifying concentrations of the different subsets of the amplified dilution-tagged mixture to generate a modified dilution-tagged mixture; and
determining an abundance of the nucleic acid target using the modified dilution-tagged mixture and the relative concentration profile associated with the different dilution tag sequence combinations.